✦ LIBER ✦
90Yttrium-Ibritumomab-Tiuxetan as First-Line Treatment for Follicular Lymphoma: 30 Months of Follow-Up Data From an International Multicenter Phase II Clinical Trial
✍ Scribed by Scholz, C. W.; Pinto, A.; Linkesch, W.; Linden, O.; Viardot, A.; Keller, U.; Hess, G.; Lastoria, S.; Lerch, K.; Frigeri, F.; Arcamone, M.; Stroux, A.; Frericks, B.; Pott, C.; Pezzutto, A.
- Book ID
- 118278641
- Publisher
- American Society of Clinical Oncology
- Year
- 2013
- Tongue
- English
- Weight
- 133 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0732-183X
No coin nor oath required. For personal study only.